RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• KoshyMEsiashvilliNLandryJCThomasCRJrMatthewsRHMultiple management modalities in esophageal cancer: combined modality management approachesOncologist20049214715915047919
   PubMed Web of Science ®Google Scholar
• GuillemotFBillaultAAuffrayCPhysical linkage of a guanine nucleotide-binding protein-related gene to the chicken major histocompatibility complexProc Natl Acad Sci U S A19898612459445982499885
   PubMed Web of Science ®Google Scholar
• ChangBYConroyKBMachlederEMCartwrightCARACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cellsMol Cell Biol1998186324532569584165
   PubMed Web of Science ®Google Scholar
• RonDJiangZYaoLVagtsADiamondIGordonACoordinated movement of RACK1 with activated betaIIPKCJ Biol Chem199927438270392704610480917
   PubMed Web of Science ®Google Scholar
• LiJJXieDRACK1, a versatile hub in cancerOncogene201534151890189824882575
   PubMed Web of Science ®Google Scholar
• McCahillAWarwickerJBolgerGBHouslayMDYarwoodSJThe RACK1 scaffold protein: a dynamic cog in cell response mechanismsMol Pharmacol20026261261127312435793
   PubMed Web of Science ®Google Scholar
• CaoXXXuJDLiuXLRACK1: a superior independent predictor for poor clinical outcome in breast cancerInt J Cancer201012751172117920020495
   PubMed Web of Science ®Google Scholar
• CaoXXXuJDXuJWRACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivoBreast Cancer Res Treat2010123237538619946739
   PubMed Web of Science ®Google Scholar
• ShiSDengYZZhaoJSRACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathwayJ Biol Chem2012287117845785822262830
   PubMed Web of Science ®Google Scholar
• ClarkASWestKABlumbergPMDennisPAAltered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistanceCancer Res200363478078612591726
   PubMed Web of Science ®Google Scholar
• RuanYSunLHaoYRibosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinomaJ Clin Invest201212272554256622653060
   PubMed Web of Science ®Google Scholar
• WangZZhangBJiangLRACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67Eur J Cancer200945349049619087901
   PubMed Web of Science ®Google Scholar
• WangNLiuFCaoFRACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transitionCancer Biol Ther201516452854025719728
   PubMed Web of Science ®Google Scholar
• IkebuchiYItoKTakadaTAnzaiNKanaiYSuzukiHReceptor for activated C-kinase 1 regulates the cell surface expression and function of ATP binding cassette G2Drug Metab Dispos201038122320232820858845
   PubMed Web of Science ®Google Scholar
• IkebuchiYTakadaTItoKReceptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4Hepatol Res200939111091110719674157
   PubMed Web of Science ®Google Scholar
• RonDChenCHCaldwellJJamiesonLOrrEMochly-RosenDCloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteinsProc Natl Acad Sci U S A19949138398438302854
   PubMed Web of Science ®Google Scholar
• AdamsDRRonDKielyPARACK1, a multifaceted scaffolding protein: structure and functionCell Commun Signal201192221978545
   PubMed Web of Science ®Google Scholar
• VoltaVBeugnetAGalloSRACK1 depletion in a mouse model causes lethality, pigmentation deficits and reduction in protein synthesis efficiencyCell Mol Life Sci20137081439145023212600
   PubMed Web of Science ®Google Scholar
• NakajimaMKatoHTreatment options for esophageal squamous cell carcinomaExpert Opin Pharmacother201314101345135423675862
   PubMed Web of Science ®Google Scholar
• LiBLiJXuWWSuppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathwayOncotarget2014522115761158725344912
   PubMedGoogle Scholar
• FalascaMPI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugsCurr Pharm Des201016121410141620166984
   PubMed Web of Science ®Google Scholar
• LoPiccoloJBlumenthalGMBernsteinWBDennisPATargeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerationsDrug Resist Updat2008111–2325018166498
   PubMed Web of Science ®Google Scholar
• ZhangXLiuNMaDReceptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathwayInt J Oncol201649253954827279145
   PubMed Web of Science ®Google Scholar
• PengRJiangBMaJForced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activityOncol Rep20133052195220224008630
   PubMed Web of Science ®Google Scholar
• WangFYamauchiMMuramatsuMOsawaTTsuchidaRShibuyaMRACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathwayJ Biol Chem2011286119097910621212275
   PubMed Web of Science ®Google Scholar
• SubausteMCVentura-HolmanTDuLRACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cellsCancer Biol Ther20098232297230519855191
   PubMed Web of Science ®Google Scholar
• SangNSeverinoARussoPRACK1 interacts with E1A and rescues E1A-induced yeast growth inhibition and mammalian cell apoptosisJ Biol Chem200127629270262703311358958
   PubMed Web of Science ®Google Scholar
• Gomez-BougiePBatailleRAmiotMEndogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cellsEur J Immunol200535397197615724238
   PubMed Web of Science ®Google Scholar
• ZhangWChengGZGongJRACK1 and CIS mediate the degradation of BimEL in cancer cellsJ Biol Chem200828324164161642618420585
   PubMed Web of Science ®Google Scholar